Dr. Stuart Lipton is an internationally renowned physician and researcher. He is who directs the laboratory currently investigating the rare disease of our children. Here it is his their curriculum vitae:
PROFESSIONAL AND SCIENTIFIC CAREER
Stuart Lipton, MD and Ph.D., is a neurologist specialized in neurodegenerative diseases. Neuroscientist and internationally renowned expert in dementia, Dr. Lipton is famous for memantine (Namenda®), approved by the FDA, the first drug in a new class of drugs used to treat Alzheimer disease.
In addition to his clinical practice in general neurology, Dr. Lipton is a prolific researcher whose studies have led him to the development of the first neuroprotective drugs, to fight against different neurodegenerative and vascular brain diseases. He is an associate professor at the Department of Neuroscience at the School of Medicine at the University of California, San Diego, and at the Department of Molecular and Experimental Medicine at the Scripps Research Institute. Dr. Lipton is also a distinguished professor “Hannah and Eugene Step” and Professor of Neurodegenerative Diseases at the Scintillon Institute in San Diego.
As translational research scientist, Dr. Lipton applies the results on basic research to produce new drugs, devices and treatments for people to improve their health and welfare. His areas of knowledge include pharmacology and stem cell biology. Dr. Lipton has widely published. He is co-author of some 500 articles and books. His work has appeared in journals such as Science, Nature, Cell, The New England Journal of Medicine, JAMA and The Lancet, among others. It has been cited about 14,000 times.
Before settling in San Diego, Dr. Lipton worked at the Medical Department at Harvard for 25 years.
Dr. Lipton completed his residency in neurology at Harvard University, where he also completed his PhD in biochemistry and biophysics. As a postdoctoral fellow in the Department of Neurobiology at Harvard University, Dr. Lipton studied under the direction of Torsten N. Wiesel, when Wiesel won the Nobel Prize in 1981. Dr. Lipton graduated in Medicine at School of Medicine at University of Pennsylvania. He is specialized in neurology.
Dr. Lipton is elected fellow of both the American Association for the Advance of Science and the American Neurological Association.
In 2004, for his work in developing the drug memantine, Dr. Lipton was the recipient of the Ernst Jung Prize in Medicine. This is considered one of the 5 or 6 top awards worldwide.
– Degree in Medicine from the University of Pennsylvania School of Medicine, Philadelphia, 1972-1977 (Phi Beta Kappa, Alpha Omega Alpha, Fellow American Academy of Neurology, Elected Fellow AAAS).
– Specialty Certificates: Neurology, 1982.
– Areas of Clinical Experience: Dementia, General Neurology.